These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Cardiovascular disease in uremic patients on hemodialysis. Lazarus JM; Lowrie EG; Hampers CL; Merrill JP Kidney Int Suppl; 1975 Jan; (2):167-75. PubMed ID: 1099301 [TBL] [Abstract][Full Text] [Related]
8. Comparison of the hemodynamic response to hemodialysis with acetate or bicarbonate. Schick EC; Idelson BA; Liang C; Redline RC; Bernard DB Trans Am Soc Artif Intern Organs; 1983; 29():25-8. PubMed ID: 6324441 [No Abstract] [Full Text] [Related]
9. Uremic cardiomyopathy and pericarditis. Drüeke T; Le Pailleur C; Zingraff J; Jungers P Adv Nephrol Necker Hosp; 1980; 9():33-70. PubMed ID: 6447440 [No Abstract] [Full Text] [Related]
10. [Phosphate binders for therapy of hyperphosphatemia causing secondary hyperparathyroidism and renal osteodystrophy in patients with chronic renal failure]. Kanagawa S; Yosikawa Y; Dohi Y Nihon Rinsho; 1991 Dec; 49 Suppl():770-4. PubMed ID: 1808348 [No Abstract] [Full Text] [Related]
11. Pathophysiological features of hypertension in CAPD: hemodynamic pattern evaluated by impedance cardiography. Di Paolo B; Santoferrara A; Del Rosso G; Di Liberato L; Amoroso L; Fiederling B; Bucciarelli S; Paolantonio L; Albertazzi A Contrib Nephrol; 1994; 106():186-9. PubMed ID: 8174369 [No Abstract] [Full Text] [Related]
13. [Treatment of hypertension in dialysis patients and renal transplant recipients]. Małyszko J; Fryc J; Myśliwiec M Przegl Lek; 2005; 62(7):694-7. PubMed ID: 16463704 [TBL] [Abstract][Full Text] [Related]
14. Phosphate binders and management of hyperphosphataemia in end-stage renal disease. Savica V; Calò LA; Monardo P; Santoro D; Bellinghieri G Nephrol Dial Transplant; 2006 Aug; 21(8):2065-8. PubMed ID: 16766546 [No Abstract] [Full Text] [Related]
15. [Correction of the acid-base equilibrium in patients with chronic renal insufficiency during hemodialysis]. Levandovskaia GI; Torgunakov AP; Astudin VP Urol Nefrol (Mosk); 1974; (1):20-2. PubMed ID: 4446132 [No Abstract] [Full Text] [Related]
16. New developments in hyperphosphatemia management. Slatopolsky E J Am Soc Nephrol; 2003 Sep; 14(9 Suppl 4):S297-9. PubMed ID: 12939384 [No Abstract] [Full Text] [Related]
17. [Cardiovascular risk in hemodialysis in Spain: prevalence, management and target results (MAR study)]. Portolés J; López-Gómez JM; Aljama P Nefrologia; 2005; 25(3):297-306. PubMed ID: 16053011 [TBL] [Abstract][Full Text] [Related]
18. [Effect of bicarbonate and acetate dialysates on hemodialysis in chronic renal failure]. Janicka L; Twardowski Z; Sokołowska G Pol Arch Med Wewn; 1981 Aug; 66(2):93-101. PubMed ID: 7033937 [No Abstract] [Full Text] [Related]
19. [Pericarditis in renal insufficiency]. Brogard JM; Arnold P Minerva Med; 1973 Oct; 64(77):4045-50. PubMed ID: 4764076 [No Abstract] [Full Text] [Related]
20. [Dialysis bone disease associated with secondary hyperparathyroidism]. Nakazawa R Nihon Rinsho; 1992 Jan; 50 Suppl():783-8. PubMed ID: 1578767 [No Abstract] [Full Text] [Related] [Next] [New Search]